Adaptive Phage Therapeutics Closes on $12 Million Investment in $30 Million Series B1 to Fight Antibiotic Resistant Infections Read More » June 13, 2023
New Data Show Genentech’s Subcutaneously Administered Crovalimab Achieved Disease Control and Was Well-Tolerated in People With Paroxysmal Nocturnal Hemoglobinuria (PNH) Read More » June 9, 2023
DxVx, Won the Governmental Project to Develop Diagnostic Sensor Kit for Adult Diseases Read More » June 9, 2023
Hememics Biotechnologies, Inc. and General Graphene Corporation Cement Strategic Partnership for Large-Scale Production of Graphene-Based Biosensors Read More » June 8, 2023
PathPresenter Empowers Biorepositories to Share Pathology Imaging Data for Biomedical Research Read More » June 7, 2023
Transgene and NEC Present New Data on TG4050, an Individualized Cancer Vaccine, Showing it Induces Specific Immune Responses Against Head and Neck Carcinoma at ASCO 2023 Read More » June 6, 2023